参考文献/References:
[1] Gernone A, Bordonaro S, Tralongo P.Optimal sequence of bone target drugs in metastatic prostatic cancer[J].Expert Rev Anticancer Ther, 2015, 15(8):923-929. DOI:10.1586/14737140.2015.1054813.
[2] Siegel R, Ma JM, Zou ZH, et al.Cancer statistics, 2014[J].CA Cancer J Clin, 2014, 64(1):9-29. DOI:10.3322/caac.21208.
[3] Hu Y, Zhao Q, Rao J, et al.Longitudinal trends in prostate cancer incidence, mortality, and survival of patients from two Shanghai city districts:a retrospective population-based cohort study, 2000-2009[J/OL].BMC Public Health, 2014, 14:356[2016-04-28].http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4005468/. DOI:10.1186/1471-2458-14-356.
[4] Yasmin-Karim S, King MR, Messing EM, et al.E-selectin ligand-1 controls circulating prostate cancer cell rolling/adhesion and metastasis[J].Oncotarget, 2014, 5(23):12097-12110. DOI:10.18632/oncotarget.2503.
[5] Choueiri MB, Tu SM, Yu-Lee LY, et al.The central role of osteoblasts in the metastasis of prostate cancer[J].Cancer Metastasis Rev, 2006, 25(4):601-609. DOI:10.1007/s10555-006-9034-y.
[6] 李建飞, 马梓友, 石贵宝, 等.前列腺癌骨转移的影像诊断分析[J].吉林医学, 2011, 32(29):6198-6199. DOI:10.3969/j.issn.1004-0412.2011.29.102.Li JF, Ma ZY, Shi GB, et al.Imaging diagnostic analysis of prostate cancer bone metastases[J].Jilin Med J, 2011, 32(29):6198-6199.
[7] 齐红艳, 孙逊, 安锐.骨转移瘤影像学检查方法及相关进展[J].华中科技大学学报:医学版, 2015, 44(1):121-124. DOI:10.3870/j.issn.1672-0741.2015.01.025.Qi HY, Sun X, An R.The examination method and related progress of bone metastases imaging[J].Acta Med Univ Sci Technol Huazhong, 2015, 44(1):121-124.
[8] Buhmann Kirchhoff S, Becker C, Duerr HR, et al.Detection of osseous metastases of the spine:comparison of high resolution multi-detector-CT with MRI[J].Eur J Radiol, 2009, 69(3):567-573. DOI:10.1016/j.ejrad.2007.11.039.
[9] 李远章, 黄杰灵, 潘智越.螺旋CT在肿瘤骨转移诊断中的价值[J].中国医药指南, 2013, 11(21):481-482. DOI:10.3969/j.issn.1671-8194.2013.21.364.Li YZ, Huang JL, Pan ZY.The value of spiral CT in tumor diagnosis of bone metastases[J].Guid Chin Med, 2013, 11(21):481-482.
[10] Chagpar A, Babiera G, Aguirre J, et al.Variation in metastatic workup for patients with invasive breast cancer[J].Am J Surg, 2015, 210(6):1147-1154. DOI:10.1016/j.amjsurg.2015.06.032.
[11] Cha MJ, Yoon YC.Clinical relevance of the apparent diffusion coefficient value of metastatic bone tumours on diffusion-weighted MRI images:differences according to the types of primary tumour, the affected bones, and clinical factors[J].ClinRadiol, 2015, 70(10):1116-1121. DOI:10.1016/j.crad.2015.05.015.
[12] Rieden K.Conventional imaging and computerized tomography in diagnosis of skeletal metastases[J].Radiologe, 1995, 35(1):15-20.
[13] Iagaru A, Young P, Mittra E, et al.Pilot prospective evaluation of 99mTc-MDP scintigraphy, 18F NaF PET/CT, 18F FDG PET/CT and whole-body MRI for detection of skeletal metastases[J/OL].Clin Nucl Med, 2013, 38(7):e290-296[2016-04-28].http://www.ncbi.nlm.nih.gov/pubmed/23455520. DOI:10.1097/RLU.0b013e3182815f64.
[14] 秦全波.前列腺癌脊椎骨转移CT、MRI检查的比较分析[J].中国实用医药, 2014, 9(25):100-101.Qin QB.Comparative analysis of prostate cancer metastasis vertebrae in CT and MRI examination[J].China Prac Med, 2014, 9(25):100-101.
[15] Bourillon C, Rahmouni A, Lin C, et al.Intravoxel incoherent motion diffusion-weighted imaging of multiple myeloma lesions:correlation with Whole-Body dynamic contrast agent-enhanced Mr imaging[J].Radiology, 2015, 277(3):773-783. DOI:10.1148/radiol.2015141728.
[16] Giles SL, Desouza NM, Collins DJ, et al.Assessing myeloma bone disease with whole-body diffusion-weighted imaging:comparison with x-ray skeletal survey by region and relationship with laboratory estimates of disease burden[J].Clin Radiol, 2015, 70(6):614-621. DOI:10.1016/j.crad.2015.02.013.
[17] Thoeny HC, De Keyzer F.Extracranial applications of diffusion-weighted magnetic resonance imaging[J].EurRadiol, 2007, 17(6):1385-1393.
[18] Vilanova JC, Barceló J.Diffusion-weighted whole-body MR screening[J].Eur J Radiol, 2008, 67(3):440-447. DOI:10.1016/j.ejrad.2008.02.040.
[19] 张伟, 薛鹏, 尹所, 等.全身弥散加权成像诊断肿瘤骨转移的应用探讨[J].中国CT和MRI杂志, 2013, 11(2):91-93. DOI:10.3969/j.issn.1672-5131.2013.02.030.Zhang W, Xue P, Yin S, et al.The clinical value of Whole-body diffusion weighted imaging on detection of bone metastasis[J].Chin J CT MRI, 2013, 11(2):91-93.
[20] Garcia JR, Moreno C, Valls E, et al.Diagnostic performance of bone scintigraphy and 11C-Choline PET/CT in the detection of bone metastases in patients with biochemical recurrence of prostate cancer[J].Rev Esp Med Nucl Imagen Mol, 2015, 34(3):155-161.
[21] 饶良俊, 王晓燕, 陈志丰, 等.对比分析99mTc-MDP SPECT与18F-NaF PET/CT术前诊断肺癌骨转移的价值[J].中国医学影像技术, 2012, 28(12):2233-2238.Rao LJ, Wang XY, Chen ZF, et al.Comparison of preoperative 99mTc-MDP SPECT and 18F-NaF PET/CT in diagnosis of bone metastases in patients with lung cancer[J].Chin J Med Imaging Technol, 2012, 28(12):2233-2238.
[22] 王东, 孟宪平, 陈则君, 等.SPECT/CT融合图像与全身骨显像对骨转移瘤诊断的价值分析[J].中国CT和MRI杂志, 2016, 14(4):126-129. DOI:10.3969/j.issn.1672-5131.2016.04.038.Wang D, Meng XP, Chen ZJ, et al.The diagnosis value analysis of SPECT/CT fusion images and whole body bone imaging for bone metastases[J].Chin J CT MRI, 2016, 14(4):126-129.
[23] Haraldsen A, Bluhme H, R?hl L, et al.Single photon emission computed tomography(SPECT) and SPECT/low-dose computerized tomography did not increase sensitivity or specificity compared to planar bone scintigraphy for detection of bone metastases in advanced breast cancer[J].Clin Physiol Funct Imaging, 2016, 36(1):40-46. DOI:10.1111/cpf.12191.
[24] 张一秋, 石洪成, 顾宇参, 等.SPECT/CT骨显像对肺癌骨转移诊断的增益价值[J].中华核医学杂志, 2011, 31(4):219-222. DOI:10.3760/cma.j.issn.0253-9780.2011.04.002.Zhang YQ, Shi HC, Gu YC, et al.The added diagnostic value of SPECT/CT imaging for bone metastases from lung cancer[J].Chin J Nucl Med, 2011, 31(4):219-222.
[25] Bailly M, Besse H, Kerdraon R, et al.18F-FDG PET/CT superscan in prostate cancer[J].Clin Nucl Med, 2014, 39(10):912-914. DOI:10.1097/RLU.0000000000000376.
[26] Byun BH, Kong CB, Lim I, et al.Comparison of 18F-FDG PET/CT and 99mTc-MDP bone scintigraphy for detection of bone metastasis in osteosarcoma[J].Skeletal Radiol, 2013, 42(12):1673-1681. DOI:10.1007/s00256-013-1714-4.
[27] Beheshti M, Langsteger W, Fogelman I.Prostate cancer:role of SPECT and PET in imaging bone metastases[J].SeminNucl Med, 2009, 39(6):396-407. DOI:10.1053/j.semnuclmed.2009.05.003.
[28] Rosen EL, Eubank WB, Mankoff DA.FDG PET, PET/CT, and breast cancer imaging[J].Radiographics, 2007, 27(Suppl 1):S215-229. DOI:10.1148/rg.27si075517.
[29] Mojtahedi A, Solomon SB, Ulaner GA.Focused regional FDG PET/CT detects more osseous metastases than does whole-body PET/CT[J].Clin Nucl Med, 2013, 38(3):217-218. DOI:10.1097/RLU.0b013e31827a27ae.
[30] 彭婕, 董爱生, 左长京, 等.肺癌脊椎骨转移18F-FDG PET/CT与MRI的对比分析[J].医学影像学杂志, 2011, 21(10):1477-1480. DOI:10.3969/j.issn.1006-9011.2011.10.007.Peng J, Dong AS, Zuo CJ, et al.Evaluation of 18F-FDG PET/CT and Mr imaging in the detection of spinal metastasis of lung cancer[J].J Med Imaging, 2011, 21(10):1477-1480.
相似文献/References:
[1]王朋,崔邦平,代文莉,等.18F-FDG PET/CT在前列腺癌中的应用进展[J].国际放射医学核医学杂志,2016,40(4):277.[doi:10.3760/cma.j.issn.1673-4114.2016.04.008]
Wang Peng,Cui Bangping,Dai Wenli,et al.Progress in the application of 18F-FDG PET/CT in prostate cancer[J].International Journal of Radiation Medicine and Nuclear Medicine,2016,40(6):277.[doi:10.3760/cma.j.issn.1673-4114.2016.04.008]
[2]张胤,陈跃.18F-氟化钠PET/CT诊断肿瘤骨转移应用进展[J].国际放射医学核医学杂志,2015,39(1):96.[doi:10.3760/cma.j.issn.1673-4114.2015.01.020]
Zhang Yin,Chen Yue.Application progress of 18F-NaF PET/CT in the diagnosis of neoplasm metastases[J].International Journal of Radiation Medicine and Nuclear Medicine,2015,39(6):96.[doi:10.3760/cma.j.issn.1673-4114.2015.01.020]
[3]刘辰,杨悦,张雪宁,等.MRI和1997年版Partin表对前列腺癌病理特征预测准确性的对比研究[J].国际放射医学核医学杂志,2015,39(2):124.[doi:10.3760/cma.j.issn.1673-4114.2015.02.005]
Liu Chen,Yang Yue,Zhang Xuening,et al.Accuracy of MRI and 1997 edition of Partin tables in predicting the pathological features of prostate cancer[J].International Journal of Radiation Medicine and Nuclear Medicine,2015,39(6):124.[doi:10.3760/cma.j.issn.1673-4114.2015.02.005]
[4]徐金苹,袁德晓,张江虹,等.辐射诱导的外泌体在肿瘤细胞侵袭转移中的作用[J].国际放射医学核医学杂志,2015,39(2):144.[doi:10.3760/cma.j.issn.1673-4114.2015.02.009]
Xu Jinping,Yuan Dexiao,Zhang Jianghong,et al.The role of radiation-induced exosomes in tumor invasion and metastasis[J].International Journal of Radiation Medicine and Nuclear Medicine,2015,39(6):144.[doi:10.3760/cma.j.issn.1673-4114.2015.02.009]
[5]刘雪辉,李洪均,于鸿煦.SPECT/CT融合显像对可疑骨转移灶的诊断效能[J].国际放射医学核医学杂志,2015,39(3):201.[doi:10.3760/cma.j.issn.1673-4114.2015.03.003]
Liu Xuehui,Li Hongjun,Yu Hongxu.Diagnostic efficacy of SPECT/CT fusion imaging in assessing possible bone metastases[J].International Journal of Radiation Medicine and Nuclear Medicine,2015,39(6):201.[doi:10.3760/cma.j.issn.1673-4114.2015.03.003]
[6]张晖,段清,卓娜,等.经直肠超声引导下“6+X”点法前列腺穿刺活检诊断前列腺癌的临床价值分析[J].国际放射医学核医学杂志,2015,39(4):308.[doi:10.3760/cma.j.issn.1673-4114.2015.04.008]
Zhang Hui,Duan Qing,Zhuo Na,et al.Meta-analysis of the diagnostic value of transrectal ultrasound-guided “6+X” points biopsy in prostate cancer[J].International Journal of Radiation Medicine and Nuclear Medicine,2015,39(6):308.[doi:10.3760/cma.j.issn.1673-4114.2015.04.008]
[7]张龙敏,刘爱连.前列腺癌MRI诊断技术研究进展[J].国际放射医学核医学杂志,2014,38(1):53.[doi:10.3760/cma.j.issn 1673-4114.2014.01.011]
Zhang Longmin,Liu Ailian.Advances in MRI diagnosis of prostate cancer[J].International Journal of Radiation Medicine and Nuclear Medicine,2014,38(6):53.[doi:10.3760/cma.j.issn 1673-4114.2014.01.011]
[8]高平,王茜,赵赟赟,等.99Tcm-MDP SPECT/CT显像用于骨肉瘤肺转移的诊断[J].国际放射医学核医学杂志,2014,38(3):148.[doi:10.3760/cma.j.issn.1673-4114.2014.03.002]
Gao Ping,Wang Qian,Zhao Yunyun,et al.99Tcm-MDP SPECT/CT used in diagnosis of pulmonary metastasis from osteosarcoma[J].International Journal of Radiation Medicine and Nuclear Medicine,2014,38(6):148.[doi:10.3760/cma.j.issn.1673-4114.2014.03.002]
[9]刘辰,杨悦,张雪宁,等.CT/MRI图像融合在前列腺癌IMRT中的应用进展[J].国际放射医学核医学杂志,2014,38(4):247.[doi:10.3760/cma.j.issn.1673-4114.2014.04.010]
Liu Chen,Yang Yue,Zhang Xuening,et al.CT/MRI image fusion in intensity modulated radiation therapy for prostate cancer[J].International Journal of Radiation Medicine and Nuclear Medicine,2014,38(6):247.[doi:10.3760/cma.j.issn.1673-4114.2014.04.010]
[10]凌彩霞,肖国有.SPECT/CT骨断层显像及在恶性肿瘤骨转移诊断中的临床价值[J].国际放射医学核医学杂志,2014,38(4):275.[doi:10.3760/cma.j.issn.1673-4114.2014.04.016]
Ling Caixia,Xiao Guoyou.The clinical value of SPECT/CT bone tomography in the diagnosis of malignant tumor metastasis[J].International Journal of Radiation Medicine and Nuclear Medicine,2014,38(6):275.[doi:10.3760/cma.j.issn.1673-4114.2014.04.016]
[11]桂继琮,刘兴党.镭-223氯化物治疗去势抵抗性前列腺癌骨转移的研究进展[J].国际放射医学核医学杂志,2015,39(3):268.[doi:10.3760/cma.j.issn.1673-4114.2015.03.018]
Gui Jicong,Liu Xingdang.Development in the study of radium-223 chloride for treating castration-resistant prostate carcinoma with bone metastases[J].International Journal of Radiation Medicine and Nuclear Medicine,2015,39(6):268.[doi:10.3760/cma.j.issn.1673-4114.2015.03.018]
[12]袁超,李卫鹏,胡永全,等.89Sr治疗乳腺癌和前列腺癌多发性骨转移的临床观察[J].国际放射医学核医学杂志,2010,34(4):220.[doi:10.3760/cma.j.issn.1673-4114.2010.04.008]
YUAN Chao,LI Wei-peng,HU Yong-quan,et al.Clinical observation of 89Sr treatment efficacy of multiple bone metastases in breast and prostate cancer patients[J].International Journal of Radiation Medicine and Nuclear Medicine,2010,34(6):220.[doi:10.3760/cma.j.issn.1673-4114.2010.04.008]
[13]徐海青,段俊,吴边.全身骨显像诊断前列腺癌骨转移与PSA水平及病理分级的相关性研究[J].国际放射医学核医学杂志,2011,35(1):34.[doi:10.3760/cma.j.issn.1673-4114.2011.01.010]
XU Hai-qing,DUAN Jun,WU Bian.Study of relationship between the bone imaging, level of PSA and pathology grade in diagnosis of prostate carcinoma bone metastasis[J].International Journal of Radiation Medicine and Nuclear Medicine,2011,35(6):34.[doi:10.3760/cma.j.issn.1673-4114.2011.01.010]
[14]耿峻,吴兴勇,胡德胜,等.前列腺癌48例患者全身核素骨显像的临床价值[J].国际放射医学核医学杂志,2007,31(4):238.